<DOC>
	<DOCNO>NCT00624741</DOCNO>
	<brief_summary>This compassionate use study design monitor safety patient well pergolide therapy , wish continue treatment , able tolerate alternative treatment .</brief_summary>
	<brief_title>Compassionate Use Study Pergolide Patients With Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Pergolide</mesh_term>
	<criteria>Diagnosed Parkinson 's disease treat successfully pergolide recent past Attempt taper pergolide unsuccessful patient unable change form therapy Parkinson 's disease No evidence cardiovalvular disease echocardiogram conduct within 60 day prior History current diagnosis cardiac valvulopathy Inability undergo echocardiogram every 6 month receive pergolide Hypersensitivity pergolide ergot derivative</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Antiparkinsonian</keyword>
	<keyword>Compassionate use</keyword>
</DOC>